GlobeNewswire

SPR Therapeutics SPRINT extensa PNS System

SPRINT extensa PNS System

SPR Therapeutics’ SPRINT extensa™ Peripheral Nerve Stimulation (PNS) System is the only FDA-cleared percutaneous PNS System. SPRINT PNS is indicated for both chronic and acute pain and is the industry’s only dual lead capable PNS platform. SPRINT, a minimally invasive and non-opioid 60-day therapy, has demonstrated significant and sustained pain relief across multiple studies. For additional information regarding safety and efficacy visit www.sprtherapeutics.com.
SPR Therapeutics, Inc.
Format

JPEG

Source

SPR Therapeutics, Inc.

Downloads